Page last updated: 2024-08-17

adenosine diphosphate and sulprostone

adenosine diphosphate has been researched along with sulprostone in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Briel, RC; Lippert, TH1
Hatae, N; Ichikawa, A; Negishi, M; Sugimoto, Y; Yamaoka, K1
Clerman, A; Doré, S; Echeverria, V1
Dovlatova, N; Fox, SC; Heptinstall, S; Johnson, AJ; Latif, ML; Manolopoulos, P; Ralevic, V; White, AE; Wijeyeratne, YD1
Khandoga, AL; Penz, SM; Schober, LJ; Siess, W1

Other Studies

5 other study(ies) available for adenosine diphosphate and sulprostone

ArticleYear
The influence of sulprostone upon platelet function: in vitro and in vivo studies.
    Advances in prostaglandin and thromboxane research, 1980, Volume: 6

    Topics: Abortion, Induced; Adenosine Diphosphate; Blood Platelets; Dinoprostone; Dose-Response Relationship, Drug; Female; Humans; Platelet Aggregation; Pregnancy; Pregnancy Trimester, Second; Prostaglandins E, Synthetic

1980
Augmentation of receptor-mediated adenylyl cyclase activity by Gi-coupled prostaglandin receptor subtype EP3 in a Gbetagamma subunit-independent manner.
    Biochemical and biophysical research communications, 2002, Jan-11, Volume: 290, Issue:1

    Topics: Adenosine Diphosphate; Adenylate Cyclase Toxin; Adenylyl Cyclases; Alprostadil; Animals; Calcium; Calmodulin; Cell Membrane; Chelating Agents; Cloning, Molecular; COS Cells; Cyclic AMP; Dinoprostone; DNA, Complementary; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Inhibitors; GTP-Binding Protein alpha Subunits, Gi-Go; Pertussis Toxin; Prostaglandins; Prostaglandins E, Synthetic; Protein Structure, Tertiary; Rats; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP3 Subtype; Sulfonamides; Virulence Factors, Bordetella

2002
Stimulation of PGE receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following beta-amyloid exposure.
    The European journal of neuroscience, 2005, Volume: 22, Issue:9

    Topics: Adenosine Diphosphate; Alprostadil; Amyloid beta-Peptides; Animals; Animals, Newborn; Blotting, Western; Cell Death; Cell Survival; Cerebral Cortex; Dinoprostone; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; L-Lactate Dehydrogenase; Mice; Mice, Inbred C57BL; Neurons; Oxidative Stress; Peptide Fragments; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP4 Subtype

2005
Detection of P2Y(14) protein in platelets and investigation of the role of P2Y(14) in platelet function in comparison with the EP(3) receptor.
    Thrombosis and haemostasis, 2008, Volume: 100, Issue:2

    Topics: Adenosine Diphosphate; Adenosine Monophosphate; Animals; Blood Platelets; Cell Adhesion Molecules; Dinoprostone; Humans; Immunoblotting; Microfilament Proteins; Microscopy, Confocal; Phosphoproteins; Phosphorylation; Platelet Aggregation; Platelet Count; Purinergic P2 Receptor Agonists; Rats; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP3 Subtype; Receptors, Purinergic P2; Uridine Diphosphate Glucose

2008
The EP3-agonist sulprostone, but not prostaglandin E2 potentiates platelet aggregation in human blood.
    Thrombosis and haemostasis, 2010, Volume: 103, Issue:6

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Blood Platelets; Cells, Cultured; Citrates; Collagen; Dinoprostone; Drug Synergism; Hirudins; Humans; Inflammation; Platelet Aggregation; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP3 Subtype; Vasoconstrictor Agents

2010